CIK 0001393434
- Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $799,174
- in 9 filings, $788K under 10b5-1 plans
Net −$799,174. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Dugel Pravin −$233K Reporting owner sold <1% of stake
- Saroj Namrata −$232K Chief Business Officer sold 14% of stake
- Heier Jeffrey S. −$112K Chief Scientific Officer sold 4% of stake
- Kaiser Peter −$103K Chief Development Officer sold 5% of stake
- Anderman Todd −$87K Chief Legal Officer sold 8% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-07-30 | CHV II, L.P. 10% owner | Conversion | +1,693,767 | 1,693,767 | ||
| 2014-07-30 | CHV II, L.P. 10% owner | Conversion | +252,525 | 252,525 | ||
| 2014-07-30 | CHV II, L.P. 10% owner | Purchase | +153,846 | $13.00 | $2.0M | 2,100,138 |
| 2014-07-30 | CHV II, L.P. 10% owner | Conversion · Series D Preferred Stock | −1,693,767 | 0 | ||
| 2014-07-30 | CHV II, L.P. 10% owner | Conversion · Series D-1 Preferred Stock | −252,525 | 0 |
Page 1 of 1 · 5 trades